CNMD - CONMED Corporation
| Previous Close | 63.14 |
| Open | 62.74 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 62.67 - 63.47 |
| 52 Week Range | 43.88 - 64.99 |
| Volume | 91,254 |
| Avg. Volume | 183,920 |
| Market Cap | 1.764B |
| Beta | 0.15 |
| PE Ratio (TTM) | 31.93 |
| EPS (TTM) | 1.97 |
| Earnings Date | Apr 25, 2018 |
| Forward Dividend & Yield | 0.80 (1.29%) |
| Ex-Dividend Date | 2018-03-14 |
| 1y Target Est | 62.50 |
Markit•10 days agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding CNMD totaled $57 million.
- Business Wire•17 days ago
CONMED Corporation to Present at Two Investor Conferences in May
CONMED Corporation today announced that it will present at the following two investor conferences in May.
- Business Wire•last month
CONMED Corporation to Announce First Quarter 2018 Financial Results on April 25, 2018
CONMED Corporation today announced that it will report financial results for the first quarter of fiscal year 2018 after the market close on Wednesday, April 25, 2018.
- GlobeNewswire•last month
Analysis: Positioning to Benefit within AnaptysBio, MoSys, CONMED, Franklin Financial Network, Hersha Hospitality Trust, and Inovalon — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Markit•last monthSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Market Realist•last monthWhy ConMed Is Expected to Report a Slight Rise in Its Net Profit Margin in 2018
ConMed (CNMD) expects to witness the positive impact of around 0.5–1.0 percentage points on its fiscal 2018 adjusted gross margin, attributable to various cost-saving initiatives. ConMed has also projected an improvement of ~0.2–0.5 percentage points in its ratio of SG&A (selling, general, and administrative) expenses to total sales for fiscal 2018 on a YoY (year-over-year) basis. ConMed also expects its 2018 R&D (research and development)-to-sales ratio to be at the higher end of the projected range of 4.5%–5%.
Market Realist•last monthWhy ConMed Is Expected to Report Robust Revenue Growth in 2018
ConMed (CNMD) expects to report revenue growth in the range of 5%–6.5% on a reported basis and in the range of 4.0%–5.0% on a CC (constant currency) basis for fiscal 2018. The company has projected a favorable top-line impact of 100–150 basis points, resulting from foreign exchange movements for fiscal 2018. In 2017, ConMed reported a ~4.3% YoY (year-over-year) rise in revenues on a CC basis, which would be in line with the average revenue growth in the medical technology industry.
- Market Realist•last month
ConMed and Peers in 2018: Analyst Recommendations
Headquartered in Utica, New York, ConMed (CNMD) currently employs 3,100 people worldwide. In 4Q17, ConMed reported total sales close to $222.6 million, which represents a YoY (year-over-year) rise of ~7.9% on a CC (constant currency) basis and 9% on a reported basis, driven by the robust uptake of its products in the US and in international geographies. For fiscal 2017, ConMed reported total sales close to $796 million, which represents a YoY rise of ~4.3%, both on a CC and reported basis.
Markit•last monthSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding CNMD totaled $352 million.
- Business Wire•last month
CONMED Corporation Announces Annual Meeting of Shareholders
CONMED Corporation today announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 23, 2018, at 2:00 p.m.
- Simply Wall St.•last month
Will CONMED Corporation’s (NASDAQ:CNMD) Earnings Grow In The Year Ahead?
In December 2017, CONMED Corporation (NASDAQ:CNMD) released its most recent earnings update. Generally, it seems that analyst forecasts are fairly pessimistic, with profits predicted to drop by -19.72% next yearRead More...
Markit•2 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Business Wire•2 months ago
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2018 to all shareholders of record as of March 15, 2018.
- GuruFocus.com•2 months ago
Conmed Corp (CNMD) Files 10-K for the Fiscal Year Ended on December 31, 2017
Conmed Corp (NASDAQ:CNMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Markit•2 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Business Wire•2 months ago
CONMED Corporation to Present at the Canaccord Genuity Musculoskeletal Conference
CONMED Corporation today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference at 10:30 a.m.
- Zacks•2 months ago
5 Reasons Why You Should Buy CONMED (CNMD) Stock Right Now
Strong market trends and share price performance fortify CONMED's (CNMD) foothold in the niche markets.
Markit•2 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Business Wire•3 months ago
CONMED Corporation to Present at the Leerink Partners 7th Annual Global Healthcare Conference
CONMED Corporation today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Leerink Partners 7th Annual Global Healthcare Conference at 9:00 a.m.
- Zacks•3 months ago
Conmed (CNMD) Beats Earnings and Revenue Estimates in Q4
Conmed (CNMD) benefits from impressive general surgery performance and enhanced innovation in Q4.
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of CNMD earnings conference call or presentation 31-Jan-18 9:30pm GMT
Q4 2017 Conmed Corp Earnings Call
- Associated Press•3 months ago
Conmed tops Street 4Q forecasts
On a per-share basis, the Utica, New York-based company said it had net income of $1.65. Earnings, adjusted for one-time gains and costs, were 69 cents per share. The results surpassed Wall Street expectations. ...
- Business Wire•3 months ago
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2017 Financial Results
CONMED Corporation today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.
- Simply Wall St.•3 months ago
Where CONMED Corporation (NASDAQ:CNMD) Stands In Terms Of Earnings Growth Against Its Industry
After reading CONMED Corporation’s (NASDAQ:CNMD) most recent earnings announcement (30 September 2017), I found it useful to look back at how the company has performed in the past and compareRead More...
- ACCESSWIRE•3 months ago
CONMED Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / January 31, 2018 / CONMED Corporation (NASDAQ: CNMD ) will be discussing their earnings results in their Q4 Earnings Call to be held on January 31, 2018 at 4:30 PM Eastern Time. ...
